4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-18-000009
Chief Operating Officer gave up 12,549 shares (to pay taxes)
- Chief Operating Officer acquired 45,434 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sardesai Niranjan · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-09 | Exercise or conversion : show line 1 in the form | +25,000 | 115,601 | D | ||
| 2018-03-09 | Shares withheld for taxes : show line 2 in the form | −6,896 | $4.51 | $31,101 | 108,705 | D |
| 2018-03-10 | Exercise or conversion : show line 3 in the form | +20,434 | 129,139 | D | ||
| 2018-03-10 | Shares withheld for taxes : show line 4 in the form | −5,653 | $4.51 | $25,495 | 123,486 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2018-03-09 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −25,000 | 25,000 | 25,000 | D |
| 2018-03-10 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −20,434 | 20,434 | 40,866 | D |
Loading xslF345X03/wf-form4_152098057831916.xml…